
Following the passing of Sir Ifeanyi Atueyi, founder and publisher of Pharmanews, on 15 July 2025, there have been calls from across the pharmacy profession and the health community affirming that his life’s mission deserves to be carried forward. Already, conversations are underway about memorial lectures, scholarships, and professional awards in his name. Quite remarkably, the Pharmaceutical Association of Nigeria Students (PANS) has for some years honoured him with the Sir Atueyi Essay and Debate competition. That initiative provides a promising foundation on which further memorials can be built.
For decades, Sir Atueyi gave the pharmacy profession voice and visibility. Through Pharmanews and his other engagements, he demonstrated sustained commitment to elevating the profession, championing ethical standards, fostering professional harmony and guiding generations of young practitioners on the path of excellence and integrity. It is this combination of inestimable values and contributions that makes his legacy so worthy of preservation.
A memorial lecture held annually under Sir Atueyi’s name can be a gathering where the most pressing issues in Pharmacy and healthcare are interrogated with rigour and candour. Such a forum could become a permanent fixture in the professional calendar, drawing voices from across Nigeria and the wider world to reflect on ethics, innovation, and service. In this way, each lecture would not only recall Sir Atueyi’s values but actively re-apply them to new challenges.
Scholarships, likewise, would give practical expression to his lifelong commitment to the young. Sir Atueyi was a mentor at heart, and many pharmacists today credit him for giving them their first encouragement, platform, or sense of belonging in the profession. A scholarship fund, endowed and sustained through contributions from professional bodies, industry stakeholders, and the diaspora, would ensure that promising students are not left behind for lack of means. Every beneficiary would be a living testimony to his conviction that pharmacy’s future depends on investment in its youth.
Professional awards, too, can carry forward his legacy by celebrating the virtues he exemplified. Such awards would serve not only to honour achievers but also to set benchmarks for what the profession should value. Such recognition can encourage young pharmacists to see integrity and service not as optional extras but as the highest honours worth striving for.
The existing PANS competition is a clear example of what can be achieved when remembrance is linked to action. This platform has allowed students to engage critically with the profession, to develop their voices, and to embody the spirit of intellectual inquiry that Sir Atueyi so deeply valued. It is a living legacy, and one that should be expanded. This expansion, combined with stronger mentoring opportunities for participants, research support, and avenues for visibility, would magnify its impact. In this way, what began as an honour could grow into a pipeline for nurturing future leaders.
It should be emphasised that for these memorials to flourish, they require thoughtful planning and wide collaboration. Government agencies, professional associations within and beyond the healthcare sector, academic institutions, and regulatory bodies have an important role to play in providing structure and visibility. Industry leaders and the pharmaceutical diaspora can lend resources and networks that give such projects stability and reach. Transparency, careful management, and continuity of vision would help ensure that these initiatives remain vibrant long after the first ceremonies have passed.
There is also the personal dimension. The best memorials are not only institutional; they are lived out in the choices of individuals. Thus, we urge senior pharmacists and other health professional to continue the responsibility of mentorship with the same accessibility and generosity that defined Sir Atueyi’s life. Healthcare leaders, in general, must continue to champion ethics, resisting the creeping commercialism that sometimes threatens professional standards. Younger practitioners and students must, in turn, be willing to learn, to uphold integrity, and to carry forward the baton. In short, if the structures we build are to succeed, they must be filled with people who embody the values they are meant to celebrate.
While Sir Atueyi’s passing may have left a space that cannot be filled by any one individual, we believe that it offers pharmacists and other stakeholders in the health sector the opportunity to institutionalise his vision and multiply his impact. Pharmanews itself stands as a living testimony to what one man’s consistency can achieve. But the responsibility now rests on all of us – practitioners, educators, regulators, students and Pharmanews staff – to ensure that his mission continues. The challenge is to ensure that the ideas being discussed are not merely well-intentioned gestures, but lasting institutions that will shape the healthcare landscape for decades to come.





